SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 235 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.09 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $134,652 | +10.4% | 4,884 | +20.3% | 0.01% | 0.0% |
| Q2 2023 | $122,014 | -10.6% | 4,059 | +7.8% | 0.01% | 0.0% |
| Q1 2023 | $136,442 | -12.0% | 3,766 | 0.0% | 0.01% | -16.7% |
| Q4 2022 | $155,084 | +22.1% | 3,766 | 0.0% | 0.01% | 0.0% |
| Q3 2022 | $127,000 | +17.6% | 3,766 | 0.0% | 0.01% | +20.0% |
| Q2 2022 | $108,000 | -11.5% | 3,766 | 0.0% | 0.01% | +25.0% |
| Q1 2022 | $122,000 | +10.9% | 3,766 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $110,000 | +10.0% | 3,766 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $100,000 | -21.3% | 3,766 | -8.7% | 0.00% | -20.0% |
| Q2 2021 | $127,000 | +17.6% | 4,123 | 0.0% | 0.01% | +25.0% |
| Q1 2021 | $108,000 | -2.7% | 4,123 | -6.7% | 0.00% | -20.0% |
| Q4 2020 | $111,000 | +20.7% | 4,418 | 0.0% | 0.01% | +25.0% |
| Q3 2020 | $92,000 | -12.4% | 4,418 | 0.0% | 0.00% | -20.0% |
| Q2 2020 | $105,000 | +32.9% | 4,418 | 0.0% | 0.01% | +25.0% |
| Q1 2020 | $79,000 | -18.6% | 4,418 | +8.2% | 0.00% | 0.0% |
| Q4 2019 | $97,000 | -13.4% | 4,082 | 0.0% | 0.00% | -20.0% |
| Q3 2019 | $112,000 | -17.0% | 4,082 | 0.0% | 0.01% | -16.7% |
| Q2 2019 | $135,000 | -5.6% | 4,082 | 0.0% | 0.01% | -14.3% |
| Q1 2019 | $143,000 | +5.1% | 4,082 | 0.0% | 0.01% | 0.0% |
| Q4 2018 | $136,000 | -34.0% | 4,082 | 0.0% | 0.01% | -30.0% |
| Q3 2018 | $206,000 | -15.6% | 4,082 | 0.0% | 0.01% | -16.7% |
| Q2 2018 | $244,000 | +31.2% | 4,082 | +0.8% | 0.01% | +33.3% |
| Q1 2018 | $186,000 | +15.5% | 4,051 | 0.0% | 0.01% | +28.6% |
| Q4 2017 | $161,000 | -13.0% | 4,051 | 0.0% | 0.01% | -22.2% |
| Q3 2017 | $185,000 | +5.7% | 4,051 | 0.0% | 0.01% | +12.5% |
| Q2 2017 | $175,000 | +37.8% | 4,051 | 0.0% | 0.01% | +33.3% |
| Q1 2017 | $127,000 | – | 4,051 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ASHFORD CAPITAL MANAGEMENT INC | 921,962 | $33,402,683 | 5.00% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 423,500 | $15,326,465 | 4.28% |
| ARMISTICE CAPITAL, LLC | 4,350,000 | $157,600,500 | 2.27% |
| S&T BANK/PA | 223,775 | $8,107 | 1.46% |
| Aristotle Capital Boston, LLC | 1,155,149 | $41,851,071 | 1.29% |
| Tributary Capital Management, LLC | 353,671 | $12,813,500 | 1.19% |
| Bridge City Capital, LLC | 62,790 | $2,274,882 | 1.14% |
| RICE HALL JAMES & ASSOCIATES, LLC | 551,285 | $19,973,056 | 1.14% |
| Intrinsic Edge Capital Management LLC | 289,704 | $10,495,976 | 1.05% |
| Parkman Healthcare Partners LLC | 131,878 | $4,777,940 | 1.04% |